These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 21592477

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
    Mihaylova B, Briggs A, Armitage J, Parish S, Gray A, Collins R, Heart Protection Study Collaborative Group.
    Lancet; ; 365(9473):1779-85. PubMed ID: 15910950
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy.
    Rublee DA, Chen SY, Mardekian J, Wu N, Rao P, Boulanger L.
    Am J Ther; 2012 Jan; 19(1):24-32. PubMed ID: 20838204
    [Abstract] [Full Text] [Related]

  • 25. Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.
    Neyt M, De Laet C, Van Brabandt H, Franco O, Ramaekers D.
    Acta Cardiol; 2009 Feb; 64(1):1-10. PubMed ID: 19317290
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?
    Ara R, Pandor A, Stevens J, Rafia R, Ward SE, Rees A, Durrington PN, Reynolds TM, Wierzbicki AS, Stevenson M.
    Eur J Prev Cardiol; 2012 Jun; 19(3):474-83. PubMed ID: 21460076
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Adherence to statin therapy saves $944 over 18 months.
    Manag Care; 2011 Jul; 20(7):47. PubMed ID: 21848200
    [No Abstract] [Full Text] [Related]

  • 32. Usefulness of a Cardiovascular Polypill in the Treatment of Secondary Prevention Patients in Spain: A Cost-effectiveness Study.
    Barrios V, Kaskens L, Castellano JM, Cosin-Sales J, Ruiz JE, Zsolt I, Fuster V, Gracia A.
    Rev Esp Cardiol (Engl Ed); 2017 Jan; 70(1):42-49. PubMed ID: 27474481
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?
    Aarnio E, Martikainen J, Winn AN, Huupponen R, Vahtera J, Korhonen MJ.
    Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):704-713. PubMed ID: 27756795
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Non-adherence to statin therapy: a major challenge for preventive cardiology.
    Bates TR, Connaughton VM, Watts GF.
    Expert Opin Pharmacother; 2009 Dec; 10(18):2973-85. PubMed ID: 19954271
    [Abstract] [Full Text] [Related]

  • 37. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B, Henriksson M, Lundin F, Wahlberg E.
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
    [Abstract] [Full Text] [Related]

  • 38. Improving Adherence to Cardiovascular Therapies: An Economic Evaluation of a Randomized Pragmatic Trial.
    Smith DH, O'Keeffe-Rosetti M, Owen-Smith AA, Rand C, Tom J, Vupputuri S, Laws R, Waterbury A, Hankerson-Dyson DD, Yonehara C, Williams A, Schneider J, Dickerson JF, Vollmer WM.
    Value Health; 2016 Apr; 19(2):176-84. PubMed ID: 27021751
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.